Working… Menu

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (CBD-IS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02051387
Recruitment Status : Completed
First Posted : January 31, 2014
Last Update Posted : March 8, 2018
University of Cologne
Information provided by (Responsible Party):
Central Institute of Mental Health, Mannheim

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2017
Actual Study Completion Date : August 2017